FOXP3 and neoplasm: It has already been shown that patients with low tumor cells FOXP3 expression and high regulatory T cells count have a significantly worse OS, suggesting that tumor FOXP3 expression could be used as a high-fidelity prognostic potential in NSCLC (28).